Memphis, Tennessee

Assessment of Needs

HCV disease management has seen rapid advances, and medical practitioners can now use direct-acting antiviral agents to treat and even cure many people. Consequently, the field needs clinical decision makers, including HIV disease management and infectious disease specialists, who are well versed in the complexities of antiretroviral management or who are involved or interested in HCV medicine to join their hepatology and gastroenterology colleagues in providing care for HCV-infected patients.

Learning Objectives

After completion of this activity, learners will be able to describe:

• Screening and testing for hepatitis C virus (HCV) infection and staging of the liver for the nonhepatologist
• Strategies for state-of-the-art treatment for HCV infection in:
  • Treatment-naive and -experienced patients
  • The setting of HCV in HIV/HCV coinfection
  • Special patient populations, such as those who have advanced liver disease
• Posttreatment screening for hepatocellular carcinoma
• The intersection of the HCV and opioid epidemics

Conflicts of Interest

In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (ie, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.

Registration

Who Should Attend

The small-group, interactive format is designed for clinical decision makers (physicians, nurse practitioners, and physician assistants) who plan to begin treating patients with HCV infection, who have experience in treating HCV infection, or who would like to update their knowledge of HCV infection management. The workshop is also suitable for PharmDs.

Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.

Cancellation Policy

Cancellation requests must be made 8 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.